The Bispecific Antibody Therapeutics market was valued at USD 641.90 Million in 2024 and is expected to reach USD 1,102.90 Million by 2032, growing at a CAGR of 7% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.